Biotech stock -- AUXL - 未名空间MITBBS历史存档

国际科技财经博客移民网络热点娱乐民生时事公众号

Redian新闻

>未名空间

>Stock

Biotech stock -- AUXL

Biotech stock -- AUXL# Stock

g*e2013-06-11 07:06

1 楼

Current price: $16.9
Catalyst evetn: Auxilium Pharmaceuticals, Inc. at Goldman Sachs Healthcare
Conference - 1:40PM EDT Jun 13, 2013
Its price is at Bottom with further big catalyst event:
Xiaflex indication for Peyronie's disease have PDUFA on 09/06/2013.
Also recent analyst updates:
Leerink upgraded Auxilium citing accretion from the Actient acquisition and
optimism for FDA approval of Xiaflex in Peyronie's disease. The firm raised
its price target for shares to $21 from $16.
Do your own DD before investing. Good luck!!

b*p2013-06-11 07:06

2 楼

不错。厉害！

S*P2013-06-11 07:06

3 楼

interesting pick. thanks for sharing.
according to wiki, PD affects up to 10% of men and with limited treatments.
Xiaflex PII plan B data looks good (except that sample size is sort of small
):
The best results were achieved with a three-treatment series of three
injections each in Study B (n=10). In Study B, patients received three
injections of Xiaflex administered one per day, separated by at least one
day each, over a one-week timeframe. Patients received two additional series
of three injections, each spaced six weeks apart. The mean baseline
deviation angle was 50.2°. At nine month follow up (post-first injections),
25% or greater reduction in deviation angle was achieved in eight out of
nine patients who completed the study (89%, 1 patient had 24% reduction in
deviation angle). Based on the investigator's global assessment, 67% of
subjects were very much improved or much improved after treatment with
Xiaflex.

b*p2013-06-11 07:06

4 楼

刚才扔了个色子，开小，等过了13号再考虑long....LOL

small
series
),

【在 S*P 的大作中提到】

: interesting pick. thanks for sharing.
: according to wiki, PD affects up to 10% of men and with limited treatments.
: Xiaflex PII plan B data looks good (except that sample size is sort of small
: ):
: The best results were achieved with a three-treatment series of three
: injections each in Study B (n=10). In Study B, patients received three
: injections of Xiaflex administered one per day, separated by at least one
: day each, over a one-week timeframe. Patients received two additional series
: of three injections, each spaced six weeks apart. The mean baseline
: deviation angle was 50.2°. At nine month follow up (post-first injections),

S*P2013-06-11 07:06

5 楼

晕[email protected]$#@%$%@#

【在 b*****p 的大作中提到】

: 刚才扔了个色子，开小，等过了13号再考虑long....LOL
:
: small
: series
: ),

g*e2013-06-11 07:06

6 楼

One more analyst upgrade: TP $28.
http://www.streetinsider.com/New+Coverage/Mizuho+Securities+Sta